期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CELLULAR IMMUNOLOGY LetPub Score 6.4
52 ratings
Rate
Reputation 7.6 Influence 5.3 Speed 7.1 | ||||||||||||||||
期刊簡稱 | CELL IMMUNOL | ||||||||||||||||
ISSN | 0008-8749 | ||||||||||||||||
E-ISSN | 1090-2163 | ||||||||||||||||
h-index | 83 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 2.70%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.journals.elsevier.com/cellular-immunology/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CIMM | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Academic Press Inc. | ||||||||||||||||
主題領域 | 生物 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1970 | ||||||||||||||||
每年文章數 | 61每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 25.37% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-8749%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) 來自Elsevier的數據: Average 5.8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 11.7 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[CELLULAR IMMUNOLOGY] 的評論 | 撰寫評論 |
作者: Arlen Lyly 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-14 16:54:14 評論於 Yesterday I submitted an article, but it was rejected after 2 hours, stating that the clinical data was not suitable for publication(0) 讚! | Arlen Lyly |
作者: 卧龙正毅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-15 22:22:04 評論於 Who should I send the reminder to? It has been over two months and my paper is still under review. The system shows that only one reviewer has reviewed it. Can I send a reminder?(0) 讚! | 卧龙正毅 |
作者: 卧龙正毅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-15 21:17:37 評論於 It has been over two months since the manuscript submission and only one reviewer has accepted and completed the review. It seems like finding reviewers is quite challenging(0) 讚! | 卧龙正毅 |
作者: 元修小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-24 12:53:50 評論於 How is your article coming along?(0) 讚! | 元修小可爱 |
作者: 卧龙正毅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-06 23:01:59 評論於 ** The official website says the First decision is 14 days, but it's been longer and still shows as "with editor." Should we follow up? I'm in a rush to graduate, so if it's going to be rejected, please do it quickly. **(0) 讚! | 卧龙正毅 |
作者: 多罗海凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-22 12:50:43 評論於 Do you want the original data? I have a set of original data that my company did not provide me because of money issues(0) 讚! | 多罗海凡 |
作者: Brook Hutt 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-04 15:43:34 評論於 May I ask how long it takes for you to receive an online message?(0) 讚! | Brook Hutt |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:26:55 評論於 Please translate the following passage into English and Japanese, and title them ":" and ":" respectively(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:51:06 評論於 Could you please provide me with more information about this product?(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 19:40:44 評論於 What is the minimum number of keywords?(0) 讚! | 上清雨真 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 18:41:49 評論於 What is the maximum number of keywords that can be included?(0) 讚! | 破戒阳平 |
作者: 无极海旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-07 12:17:04 評論於 The paper was received online, and it took half a month to change its status to under review after revision. It was finally accepted at the end of June, three weeks later(0) 讚! | 无极海旺 |
作者: 努力啊大白山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-30 23:51:45 評論於 The latest IF=4.868(0) 讚! | 努力啊大白山 |
作者: 努力啊大白山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-24 15:53:28 評論於 2021-4-1 Submitted to Journal 2021-4-1 With Editor 2021-4-14 Under Review 2021-5-3 Under Review 2021-5-18 Major Revise 2021-6-5 re-Submitted to Journal 2021-6-5 With Editor 2021-6-5 Under Review 2021-6-21 Required Reviews Completed 2021-6-24 Accept The entire submission process took nearly three months, with the main reviewer being too slow and the editorial efficiency being acceptable. There were two reviewers, both providing a lot of revision comments and requesting additional experiments, which were all rejected. After replying to the comments, there were over ten pages of PDF. Overall, the submission difficulty was moderate(0) 讚! | 努力啊大白山 |
作者: 能帮我发SCI嘛 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-06-24 09:24:27 評論於 2021-4-1 Submitted to Journal 2021-4-1 With Editor 2021-4-14 Under Review 2021-5-3 Under Review 2021-5-18 Major Revise 2021-6-5 re-Submitted to Journal 2021-6-5 With Editor 2021-6-5 Under Review 2021-6-21 Required Reviews Completed 2021-6-24 Accept The entire submission process took nearly 3 months, with the main reviewers being slow in their speed, while the efficiency of the editorial department was decent. There were two reviewers who provided numerous modification suggestions and requested additional experiments, but all requests for additional experiments were rejected. After responding to the comments, there were over ten pages of PDF. Overall, the difficulty of the submission was moderate.(3) 讚! | 能帮我发SCI嘛 |
作者: 华清雁香 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-21 22:26:31 評論於 How is your article coming along?(0) 讚! | 华清雁香 |
作者: 无极海旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-19 14:49:07 評論於 I sent a reminder email, and the journal manager replied saying it has been rejected by 14 reviewers, but is still under consideration for invitation. The manager also helped me by submitting my reminder email to the editor(0) 讚! | 无极海旺 |
作者: 龙鳞兰梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-17 11:23:51 評論於 How can I see the rejected manuscript?(0) 讚! | 龙鳞兰梦 |
作者: 努力啊大白山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-13 12:50:22 評論於 My application is still under review(0) 讚! | 努力啊大白山 |
作者: 无极海旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-13 12:21:56 評論於 The editor requested revised submissions of the manuscript, one with track changes for review and one without for publication. They mentioned that there may be a need for a re-review, but they do not anticipate sending it to any additional reviewers. How do you feel about this?(0) 讚! | 无极海旺 |
作者: 努力啊大白山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-12 18:37:05 評論於 Can you please translate the following paragraph into English and Japanese and submit the revised version? Will it be sent back for review again?(0) 讚! | 努力啊大白山 |
作者: 无极海旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-12 08:01:43 評論於 Today the editor replied, so I made revisions and resubmitted. Only one reviewer provided feedback, while 14 reviewers rejected the submission(0) 讚! | 无极海旺 |
作者: 无极海旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-10 22:56:02 評論於 Has your status changed yet? My under review date has changed 3 times already, around the same time as yours. The last date change was on May 1st(0) 讚! | 无极海旺 |
作者: 努力啊大白山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-04 19:39:16 評論於 April 14th, under review May 3rd, under review Dates changed, but status unchanged(0) 讚! | 努力啊大白山 |
作者: 无极海旺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-02 20:59:28 評論於 Research focus: Immunology Experience sharing: Submitted on April 6th, date changed three times after being under review, on April 16th, April 28th, May 1st, still under review now. Originally aiming to submit for the first decision with a 2.4-week turnaround time as mentioned on the homepage, but still no news. Sent a reminder email yesterday, but the editor has not replied, feeling helpless and can only pray for a miracle!(0) 讚! | 无极海旺 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us